<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Asymmetric dimethylarginine,Amino acid,Arginine,Blood plasma,By-product,Carbon,Cardiovascular,Cardiovascular disease,Chemical formula,Cholesterol,Circulatory system" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Asymmetric dimethylarginine - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Asymmetric dimethylarginine</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table id="natOrganicBox" cellpadding="1" style="background-color: #ffffff; border: 1px solid #aaa; clear: right; float: right; font-size: 95%; margin: 0 0 0.5em 1em; width: 280px;">
<tr>
<td align="center" colspan="2"><a href="../../../a/d/m/Image%7EADMArazorback.jpg_afe0.html" class="image" title=""><img src="../../../upload/thumb/a/a9/ADMArazorback.jpg/150px-ADMArazorback.jpg" alt="" width="150" height="265" longdesc="../../../a/d/m/Image%7EADMArazorback.jpg_afe0.html" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<p style="font-size:medium; line-height:167%;">Asymmetric dimethylarginine</p>
</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="../../../i/u/p/IUPAC_name_bc60.html" title="IUPAC name">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">2-amino-5-[(amino-dimethylamino-methylidene)amino]&lt;br /&gt;pentanoic acid</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td style="background-color: #F8EABA; width: 20%;"><span style="white-space: nowrap;"><a href="../../../p/u/b/PubChem_a50b.html" title="PubChem">PubChem</a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
<td style="background-color: #eeeeee; width: 80%;"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=123831" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=123831" rel="nofollow">123831</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#F8EABA"><a href="../../../c/h/e/Chemical_formula.html" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="../../../c/a/r/Carbon.html" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>8</sub><a href="../../../h/y/d/Hydrogen.html" title="Hydrogen"><span style="color: rgb(154,154,154); font-weight: bold;">H</span></a><sub>18</sub><a href="../../../n/i/t/Nitrogen.html" title="Nitrogen"><span style="color: rgb(000,000,255); font-weight: bold;">N</span></a><sub>4</sub><a href="../../../o/x/y/Oxygen.html" title="Oxygen"><span style="color: rgb(232,070,070); font-weight: bold;">O</span></a><sub>2</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#F8EABA"><a href="../../../m/o/l/Molecular_weight.html" title="Molecular weight">Mol. weight</a></td>
<td bgcolor="#EEEEEE">202.25</td>
</tr>
<tr>
<td bgcolor="#F8EABA"><a href="../../../s/i/m/Simplified_molecular_input_line_entry_specification.html" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE">CN(C)C(=NCCCC(C(=O)O)N)N</td>
</tr>
<tr>
<td colspan="2" style="background-color: #dddddd; text-align: center;"><small>Complete data</small></td>
</tr>
</table>
<p><b>Asymmetric dimethylarginine</b> (ADMA) is a naturally occurring chemical found in <a href="../../../b/l/o/Blood_plasma.html" title="Blood plasma">blood plasma</a>. It is a <a href="../../../m/e/t/Metabolism.html" title="Metabolism">metabolic</a> <a href="../../../b/y/-/By-product.html" title="By-product">by-product</a> of continual <a href="../../../p/r/o/Protein.html" title="Protein">protein</a> modification processes in the <a href="../../../c/y/t/Cytoplasm.html" title="Cytoplasm">cytoplasm</a> of all human cells. It is closely related to L-<a href="../../../a/r/g/Arginine.html" title="Arginine">arginine</a>, a conditionally-essential <a href="../../../a/m/i/Amino_acid.html" title="Amino acid">amino acid</a>. ADMA interferes with L-arginine in the production of <a href="../../../n/i/t/Nitric_oxide.html" title="Nitric oxide">nitric oxide</a>, a key chemical to <a href="../../../e/n/d/Endothelium.html" title="Endothelium">endothelial</a> and hence <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">cardiovascular</a> health.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Discovery"><span class="tocnumber">1</span> <span class="toctext">Discovery</span></a></li>
<li class="toclevel-1"><a href="#Synthesis_and_regulation_in_the_body"><span class="tocnumber">2</span> <span class="toctext">Synthesis and regulation in the body</span></a></li>
<li class="toclevel-1"><a href="#ADMA_and_suggested_lines_of_therapeutic_research"><span class="tocnumber">3</span> <span class="toctext">ADMA and suggested lines of therapeutic research</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">4</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#Notes"><span class="tocnumber">5</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">6</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Discovery" id="Discovery"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: Discovery">edit</a>]</span> <span class="mw-headline">Discovery</span></h2>
<p>Patrick Vallance and his <a href="../../../l/o/n/London.html" title="London">London</a> co-workers first noted the interference role for asymmetric dimethylarginine;<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup> today biochemical and clinical research continues into its role in <a href="../../../c/a/r/Cardiovascular_disease.html" title="Cardiovascular disease">cardiovascular disease</a>, <a href="../../../d/i/a/Diabetes_mellitus.html" title="Diabetes mellitus">diabetes mellitus</a>, <a href="../../../e/r/e/Erectile_dysfunction.html" title="Erectile dysfunction">erectile dysfunction</a> and certain forms of <a href="../../../k/i/d/Kidney.html" title="Kidney">kidney</a> disease. The nitric oxide pathway is very important and ADMA appears significant to it.</p>
<p><a name="Synthesis_and_regulation_in_the_body" id="Synthesis_and_regulation_in_the_body"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: Synthesis and regulation in the body">edit</a>]</span> <span class="mw-headline">Synthesis and regulation in the body</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:212px;"><a href="../../../h/e/a/Image%7EHeart-and-lungs.jpg_066f.html" class="internal" title="Cardiovascular effects have been linked to ADMA"><img src="../../../upload/shared/thumb/e/e6/Heart-and-lungs.jpg/210px-Heart-and-lungs.jpg" alt="Cardiovascular effects have been linked to ADMA" width="210" height="205" longdesc="../../../h/e/a/Image%7EHeart-and-lungs.jpg_066f.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../h/e/a/Image%7EHeart-and-lungs.jpg_066f.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="../../../c/a/r/Cardiovascular.html" title="Cardiovascular">Cardiovascular</a> effects have been linked to ADMA</div>
</div>
</div>
<p>Asymmetric dimethylarginine is created in protein <a href="../../../m/e/t/Methylation.html" title="Methylation">methylation</a>, a common mechanism of post-translational protein modification. This reaction is catalyzed by an <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzyme</a> set called S-adenosylmethionine protein N-methyltransferases (protein methylases I and II).<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup> The methyl groups transferred to create ADMA are derived from the <a href="../../../m/e/t/Methyl.html" title="Methyl">methyl</a> group donor S-adenosylmethionine, an intermediate in the metabolism of <a href="../../../h/o/m/Homocysteine.html" title="Homocysteine">homocysteine</a>. (Homocysteine is an important blood chemical, because it is also a <a href="../../../g/e/n/Genetic_marker.html" title="Genetic marker">marker</a> of cardiovascular disease). After <a href="../../../s/y/n/Synthesis.html" title="Synthesis">synthesis</a>, ADMA migrates into the <a href="../../../e/x/t/Extracellular.html" title="Extracellular">extracellular</a> space and thence into blood plasma. Asymmetric dimethylarginine is measured using <a href="../../../h/i/g/High_performance_liquid_chromatography.html" title="High performance liquid chromatography">high performance liquid chromatography</a>.</p>
<p>ADMA concentrations are substantially elevated by native or oxidized <a href="../../../l/d/l/LDL_0aa2.html" title="LDL">LDL</a> <a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">cholesterol</a>.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup> Thus a spiralling effect occurs with high endothelial LDL levels causing greater ADMA values, which in turn inhibit NO production needed to promote <a href="../../../v/a/s/Vasodilation.html" title="Vasodilation">vasodilation</a>. The elimination of ADMA occurs through urine excretion and metabolism by the enzyme <a href="../../../d/i/m/Dimethylarginine_dimethylaminohydrolase.html" title="Dimethylarginine dimethylaminohydrolase">dimethylarginine dimethylaminohydrolase</a> (DDAH). The role of homocysteine as a risk factor for cardiovascular disease is suggested to be mediated by homocysteine down-regulating production of DDAH in the body. <a href="../../../p/o/l/Polyphenol_antioxidant.html" title="Polyphenol antioxidant">Polyphenol antioxidants</a> also play a role in down-regulating homocysteine.</p>
<p><a name="ADMA_and_suggested_lines_of_therapeutic_research" id="ADMA_and_suggested_lines_of_therapeutic_research"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: ADMA and suggested lines of therapeutic research">edit</a>]</span> <span class="mw-headline">ADMA and suggested lines of therapeutic research</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:162px;"><a href="../../../k/i/d/Image%7EKidney_section.jpg_095d.html" class="internal" title="ADMA may play a role in certain forms of kidney disease"><img src="../../../upload/thumb/b/b0/Kidney_section.jpg/160px-Kidney_section.jpg" alt="ADMA may play a role in certain forms of kidney disease" width="160" height="269" longdesc="../../../k/i/d/Image%7EKidney_section.jpg_095d.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../k/i/d/Image%7EKidney_section.jpg_095d.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
ADMA may play a role in certain forms of <a href="../../../k/i/d/Kidney.html" title="Kidney">kidney</a> disease</div>
</div>
</div>
<p>With raised levels of ADMA seemingly to be associated with adverse human health consequences for cardiovascular disease, metabolic diseases and also a wide range of diseases of the elderly, the possible lowering of ADMA levels may have important therapeutic effects. However it has yet to be established whether ADMA levels can be manipulated and, more importantly, if this results in useful clinical benefits.</p>
<p>The association of ADMA with abnormalities of lipid regulation suggested that supplements of <a href="../../../f/a/t/Fatty_acid.html" title="Fatty acid">free fatty acids</a> might manipulate ADMA levels. However research has failed to show that these have an effect.<sup id="_ref-NutrMetab2006-Eid_0" class="reference"><a href="#_note-NutrMetab2006-Eid" title="">[4]</a></sup><sup id="_ref-HormMetabRes2005-Namiranian_0" class="reference"><a href="#_note-HormMetabRes2005-Namiranian" title="">[5]</a></sup></p>
<p>ADMA role has been linked with elevated levels of <a href="../../../h/o/m/Homocysteine.html" title="Homocysteine">homocysteine</a>.<sup id="_ref-Atherosclerosis2006-Krzyzanowska_0" class="reference"><a href="#_note-Atherosclerosis2006-Krzyzanowska" title="">[6]</a></sup><sup id="_ref-VascMed2006-Dayal_0" class="reference"><a href="#_note-VascMed2006-Dayal" title="">[7]</a></sup><sup id="_ref-CurrDrugMetab2005-Stuhlinger_0" class="reference"><a href="#_note-CurrDrugMetab2005-Stuhlinger" title="">[8]</a></sup> Whilst approaches at modifying the later with oral supplements of <a href="../../../f/o/l/Folic_acid.html" title="Folic acid">folic acid</a> were strongly suggested, studies have shown this fails to give any clinical benefit and suggested that B vitamins might instead increase some cardiovascular risks.<sup id="_ref-JAmCollCardiol2006-Zoungas_0" class="reference"><a href="#_note-JAmCollCardiol2006-Zoungas" title="">[9]</a></sup><sup id="_ref-NEJM2006a_0" class="reference"><a href="#_note-NEJM2006a" title="">[10]</a></sup><sup id="_ref-3" class="reference"><a href="#_note-3" title="">[11]</a></sup></p>
<p>Direct alteration of ADMA levels with supplements of L-arginine have been suggested.<sup id="_ref-VascMed2003-Bode-Boger_0" class="reference"><a href="#_note-VascMed2003-Bode-Boger" title="">[12]</a></sup><sup id="_ref-4" class="reference"><a href="#_note-4" title="">[13]</a></sup> The hope is that such intervention might not only improve endothelial function but also reduce clinical symptoms of overt cardiovascular disease.<sup id="_ref-5" class="reference"><a href="#_note-5" title="">[14]</a></sup><sup id="_ref-6" class="reference"><a href="#_note-6" title="">[15]</a></sup> However studies show inconsistency in results in a clinical context,<sup id="_ref-JNutr2004-Loscalzo_0" class="reference"><a href="#_note-JNutr2004-Loscalzo" title="">[16]</a></sup> and the recent results with manipulating homocysteine levels warrant extreme care with what clinical outcomes might arise from this approach.</p>
<p><a href="../../../s/t/a/Statin.html" title="Statin">Statins</a>, as well as affecting circulating cholesterol levels, also increase nitric oxide levels and so have a direct effect on blood supply to the heart. Elevated levels of ADMA seems to modify this effect and so may have consequences for patients' responsiveness to taking statins.<sup id="_ref-VascMed2003-Janatuinen_0" class="reference"><a href="#_note-VascMed2003-Janatuinen" title="">[17]</a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../a/r/g/Arginine.html" title="Arginine">Arginine</a></li>
<li><a href="../../../c/a/r/Cardiovascular_disease.html" title="Cardiovascular disease">Cardiovascular disease</a></li>
<li><a href="../../../h/y/p/Hypertension.html" title="Hypertension">Hypertension</a></li>
<li><a href="../../../n/i/t/Nitric_oxide.html" title="Nitric oxide">Nitric oxide</a></li>
<li><a href="../../../s/t/a/Statin.html" title="Statin">Statins</a></li>
<li><a href="../../../v/a/s/Vasoconstriction.html" title="Vasoconstriction">Vasoconstriction</a></li>
</ul>
<p><a name="Notes" id="Notes"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: Notes">edit</a>]</span> <span class="mw-headline">Notes</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Vallance P., Leone A., Calver A., Collier J., Moncada S. (1992). "Endogenous dimethyl-arginine as an inhibitor of nitric oxide synthesis". <i>J. Cardiovasc. Pharmacol</i> <b>20</b> (Suppli. 12): S60-S62.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Endogenous+dimethyl-arginine+as+an+inhibitor+of+nitric+oxide+synthesis&amp;rft.title=J.+Cardiovasc.+Pharmacol&amp;rft.jtitle=J.+Cardiovasc.+Pharmacol&amp;rft.date=1992&amp;rft.volume=20&amp;rft.issue=Suppli.+12&amp;rft.au=Vallance+P.%2C+Leone+A.%2C++Calver+A.%2C++Collier+J.%2C+Moncada+S.&amp;rft.pages=S60-S62">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">Rawal N, Rajpurohit R, Lischwe MA, Williams KR, Paik WK, Kim S (1995). "Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases". <i>Biochim Biophys Acta</i> <b>1248</b> (1): 11-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7536038" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7536038">PMID 7536038</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Structural+specificity+of+substrate+for+S-adenosylmethionine%3Aprotein+arginine+N-methyltransferases&amp;rft.title=Biochim+Biophys+Acta&amp;rft.jtitle=Biochim+Biophys+Acta&amp;rft.date=1995&amp;rft.volume=1248&amp;rft.issue=1&amp;rft.au=Rawal+N%2C+Rajpurohit+R%2C+Lischwe+MA%2C+Williams+KR%2C+Paik+WK%2C+Kim+S&amp;rft.pages=11-8">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite style="font-style:normal">Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM (2000). "<a href="http://circres.ahajournals.org/cgi/content/full/87/2/99" class="external text" title="http://circres.ahajournals.org/cgi/content/full/87/2/99" rel="nofollow">LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases</a>". <i>Circ Res</i> <b>87</b> (2): 99-105. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10903992" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10903992">PMID 10903992</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=LDL+cholesterol+upregulates+synthesis+of+asymmetrical+dimethylarginine+in+human+endothelial+cells%3A+involvement+of+S-adenosylmethionine-dependent+methyltransferases&amp;rft.title=Circ+Res&amp;rft.jtitle=Circ+Res&amp;rft.date=2000&amp;rft.volume=87&amp;rft.issue=2&amp;rft.au=Boger+RH%2C+Sydow+K%2C+Borlak+J%2C+Thum+T%2C+Lenzen+H%2C+Schubert+B%2C+Tsikas+D%2C+Bode-Boger+SM&amp;rft.pages=99-105&amp;rft_id=http%3A%2F%2Fcircres.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F87%2F2%2F99">&#160;</span></li>
<li id="_note-NutrMetab2006-Eid"><b><a href="#_ref-NutrMetab2006-Eid_0" title="">^</a></b> <cite style="font-style:normal">Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I (2006). "<a href="http://www.nutritionandmetabolism.com/content/3/1/4" class="external text" title="http://www.nutritionandmetabolism.com/content/3/1/4" rel="nofollow">Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine</a>". <i>Nutr Metab (Lond)</i> <b>3</b>: 4. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16396682" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16396682">PMID 16396682</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+diet+and+omega-3+fatty+acid+intervention+on+asymmetric+dimethylarginine&amp;rft.title=Nutr+Metab+%28Lond%29&amp;rft.jtitle=Nutr+Metab+%28Lond%29&amp;rft.date=2006&amp;rft.volume=3&amp;rft.au=Eid+HM%2C+Arnesen+H%2C+Hjerkinn+EM%2C+Lyberg+T%2C+Ellingsen+I%2C+Seljeflot+I&amp;rft.pages=4&amp;rft_id=http%3A%2F%2Fwww.nutritionandmetabolism.com%2Fcontent%2F3%2F1%2F4">&#160;</span></li>
<li id="_note-HormMetabRes2005-Namiranian"><b><a href="#_ref-HormMetabRes2005-Namiranian_0" title="">^</a></b> <cite style="font-style:normal">Namiranian K, Mittermayer F, Artwohl M, Pleiner J, Schaller G, Mayer BX, Bayerle-Eder M, Roden M, Baumgartner-Parzer S, Wolzt M (2005). "Free fatty acids do not acutely increase asymmetrical dimethylarginine concentrations". <i>Horm Metab Res</i> <b>37</b> (12): 768-72. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16372232" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16372232">PMID 16372232</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Free+fatty+acids+do+not+acutely+increase+asymmetrical+dimethylarginine+concentrations&amp;rft.title=Horm+Metab+Res&amp;rft.jtitle=Horm+Metab+Res&amp;rft.date=2005&amp;rft.volume=37&amp;rft.issue=12&amp;rft.au=Namiranian+K%2C+Mittermayer+F%2C+Artwohl+M%2C+Pleiner+J%2C+Schaller+G%2C+Mayer+BX%2C+Bayerle-Eder+M%2C+Roden+M%2C+Baumgartner-Parzer+S%2C+Wolzt+M&amp;rft.pages=768-72">&#160;</span></li>
<li id="_note-Atherosclerosis2006-Krzyzanowska"><b><a href="#_ref-Atherosclerosis2006-Krzyzanowska_0" title="">^</a></b> <cite style="font-style:normal">Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G (2006). "Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes". <i>Atherosclerosis</i>. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16414052" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16414052">PMID 16414052</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Asymmetric+dimethylarginine+is+associated+with+macrovascular+disease+and+total+homocysteine+in+patients+with+type+2+diabetes&amp;rft.title=Atherosclerosis&amp;rft.jtitle=Atherosclerosis&amp;rft.date=2006&amp;rft.au=Krzyzanowska+K%2C+Mittermayer+F%2C+Krugluger+W%2C+Schnack+C%2C+Hofer+M%2C+Wolzt+M%2C+Schernthaner+G">&#160;</span></li>
<li id="_note-VascMed2006-Dayal"><b><a href="#_ref-VascMed2006-Dayal_0" title="">^</a></b> <cite style="font-style:normal">Dayal S, Lentz SR (2005). "ADMA and hyperhomocysteinemia". <i>Vasc Med</i> <b>10 Suppl 1</b>: S27-33. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16444866" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16444866">PMID 16444866</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=ADMA+and+hyperhomocysteinemia&amp;rft.title=Vasc+Med&amp;rft.jtitle=Vasc+Med&amp;rft.date=2005&amp;rft.volume=10+Suppl+1&amp;rft.au=Dayal+S%2C+Lentz+SR&amp;rft.pages=S27-33">&#160;</span></li>
<li id="_note-CurrDrugMetab2005-Stuhlinger"><b><a href="#_ref-CurrDrugMetab2005-Stuhlinger_0" title="">^</a></b> <cite style="font-style:normal">Stuhlinger MC, Stanger O (2005). "Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction". <i>Curr Drug Metab</i> <b>6</b> (1): 3-14. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15720202" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15720202">PMID 15720202</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Asymmetric+dimethyl-L-arginine+%28ADMA%29%3A+a+possible+link+between+homocyst%28e%29ine+and+endothelial+dysfunction&amp;rft.title=Curr+Drug+Metab&amp;rft.jtitle=Curr+Drug+Metab&amp;rft.date=2005&amp;rft.volume=6&amp;rft.issue=1&amp;rft.au=Stuhlinger+MC%2C+Stanger+O&amp;rft.pages=3-14">&#160;</span></li>
<li id="_note-JAmCollCardiol2006-Zoungas"><b><a href="#_ref-JAmCollCardiol2006-Zoungas_0" title="">^</a></b> <cite style="font-style:normal">Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ (2006). "Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial". <i>J Am Coll Cardiol</i> <b>47</b> (6): 1108-16. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16545638" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16545638">PMID 16545638</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Cardiovascular+morbidity+and+mortality+in+the+Atherosclerosis+and+Folic+Acid+Supplementation+Trial+%28ASFAST%29+in+chronic+renal+failure%3A+a+multicenter%2C+randomized%2C+controlled+trial&amp;rft.title=J+Am+Coll+Cardiol&amp;rft.jtitle=J+Am+Coll+Cardiol&amp;rft.date=2006&amp;rft.volume=47&amp;rft.issue=6&amp;rft.au=Zoungas+S%2C+McGrath+BP%2C+Branley+P%2C+Kerr+PG%2C+Muske+C%2C+Wolfe+R%2C+Atkins+RC%2C+Nicholls+K%2C+Fraenkel+M%2C+Hutchison+BG%2C+Walker+R%2C+McNeil+JJ&amp;rft.pages=1108-16">&#160;</span></li>
<li id="_note-NEJM2006a"><b><a href="#_ref-NEJM2006a_0" title="">^</a></b> <cite style="font-style:normal">(2006) "<a href="http://content.nejm.org/cgi/reprint/NEJMoa060900v1.pdf" class="external text" title="http://content.nejm.org/cgi/reprint/NEJMoa060900v1.pdf" rel="nofollow">Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease</a>". <i>N Engl J Med</i>. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16531613" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16531613">PMID 16531613</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Homocysteine+Lowering+with+Folic+Acid+and+B+Vitamins+in+Vascular+Disease&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2006&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Freprint%2FNEJMoa060900v1.pdf">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006). "<a href="http://content.nejm.org/cgi/reprint/NEJMoa055227v1.pdf" class="external text" title="http://content.nejm.org/cgi/reprint/NEJMoa055227v1.pdf" rel="nofollow">Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction</a>". <i>N Engl J Med</i>. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16531614" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16531614">PMID 16531614</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Homocysteine+Lowering+and+Cardiovascular+Events+after+Acute+Myocardial+Infarction&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2006&amp;rft.au=Bonaa+KH%2C+Njolstad+I%2C+Ueland+PM%2C+Schirmer+H%2C+Tverdal+A%2C+Steigen+T%2C+Wang+H%2C+Nordrehaug+JE%2C+Arnesen+E%2C+Rasmussen+K&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Freprint%2FNEJMoa055227v1.pdf">&#160;</span></li>
<li id="_note-VascMed2003-Bode-Boger"><b><a href="#_ref-VascMed2003-Bode-Boger_0" title="">^</a></b> <cite style="font-style:normal">Bode-Boger SM, Muke J, Surdacki A, Brabant G, Boger RH, Frolich JC (2003). "Oral L-arginine improves endothelial function in healthy individuals older than 70 years". <i>Vasc Med</i> <b>8</b> (2): 77-81. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14518608" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14518608">PMID 14518608</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Oral+L-arginine+improves+endothelial+function+in+healthy+individuals+older+than+70+years&amp;rft.title=Vasc+Med&amp;rft.jtitle=Vasc+Med&amp;rft.date=2003&amp;rft.volume=8&amp;rft.issue=2&amp;rft.au=Bode-Boger+SM%2C+Muke+J%2C+Surdacki+A%2C+Brabant+G%2C+Boger+RH%2C+Frolich+JC&amp;rft.pages=77-81">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite class="book" style="font-style:normal">John P. Cooke (2002). <i>The Cardiovascular Cure</i>. Random House. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-7679-0881-3</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Cardiovascular+Cure&amp;rft.title=The+Cardiovascular+Cure&amp;rft.au=John+P.+Cooke&amp;rft.date=2002&amp;rft.pub=Random+House">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <cite style="font-style:normal">Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH (1996). "<a href="http://circ.ahajournals.org/cgi/content/full/93/12/2135" class="external text" title="http://circ.ahajournals.org/cgi/content/full/93/12/2135" rel="nofollow">Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure</a>". <i>Circulation</i> <b>93</b> (12): 2135-41. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8925582" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8925582">PMID 8925582</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Randomized%2C+double-blind%2C+placebo-controlled+study+of+supplemental+oral+L-arginine+in+patients+with+heart+failure&amp;rft.title=Circulation&amp;rft.jtitle=Circulation&amp;rft.date=1996&amp;rft.volume=93&amp;rft.issue=12&amp;rft.au=Rector+TS%2C+Bank+AJ%2C+Mullen+KA%2C+Tschumperlin+LK%2C+Sih+R%2C+Pillai+K%2C+Kubo+SH&amp;rft.pages=2135-41&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F93%2F12%2F2135">&#160;</span></li>
<li id="_note-6"><b><a href="#_ref-6" title="">^</a></b> <cite style="font-style:normal">Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K (1997). "Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris". <i>Am J Cardiol</i> <b>80</b> (3): 331-3. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9264427" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9264427">PMID 9264427</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+supplemental+oral+L-arginine+on+exercise+capacity+in+patients+with+stable+angina+pectoris&amp;rft.title=Am+J+Cardiol&amp;rft.jtitle=Am+J+Cardiol&amp;rft.date=1997&amp;rft.volume=80&amp;rft.issue=3&amp;rft.au=Ceremuzynski+L%2C+Chamiec+T%2C+Herbaczynska-Cedro+K&amp;rft.pages=331-3">&#160;</span></li>
<li id="_note-JNutr2004-Loscalzo"><b><a href="#_ref-JNutr2004-Loscalzo_0" title="">^</a></b> <cite style="font-style:normal">Loscalzo J (2004). "<a href="http://www.nutrition.org/cgi/content/full/134/10/2798S" class="external text" title="http://www.nutrition.org/cgi/content/full/134/10/2798S" rel="nofollow">L-arginine and atherothrombosis</a>". <i>J Nutr</i> <b>134</b> (10 Suppl): 2798S-2800S; discussion 2818S-2819S. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15465788" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15465788">PMID 15465788</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=L-arginine+and+atherothrombosis&amp;rft.title=J+Nutr&amp;rft.jtitle=J+Nutr&amp;rft.date=2004&amp;rft.volume=134&amp;rft.issue=10+Suppl&amp;rft.au=Loscalzo+J&amp;rft.pages=2798S-2800S%3B+discussion+2818S-2819S&amp;rft_id=http%3A%2F%2Fwww.nutrition.org%2Fcgi%2Fcontent%2Ffull%2F134%2F10%2F2798S">&#160;</span></li>
<li id="_note-VascMed2003-Janatuinen"><b><a href="#_ref-VascMed2003-Janatuinen_0" title="">^</a></b> <cite style="font-style:normal">Janatuinen T, Laakso J, Laaksonen R, Vesalainen R, Nuutila P, Lehtimaki T, Raitakari OT, Knuuti J (2003). "Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults". <i>Vasc Med</i> <b>8</b> (3): 185-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14989559" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14989559">PMID 14989559</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Plasma+asymmetric+dimethylarginine+modifies+the+effect+of+pravastatin+on+myocardial+blood+flow+in+young+adults&amp;rft.title=Vasc+Med&amp;rft.jtitle=Vasc+Med&amp;rft.date=2003&amp;rft.volume=8&amp;rft.issue=3&amp;rft.au=Janatuinen+T%2C+Laakso+J%2C+Laaksonen+R%2C+Vesalainen+R%2C+Nuutila+P%2C+Lehtimaki+T%2C+Raitakari+OT%2C+Knuuti+J&amp;rft.pages=185-9">&#160;</span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/s/y/Asymmetric_dimethylarginine.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=31545" class="external text" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=31545" rel="nofollow">ADMA article, Medical News Today, March 27, 2006</a></li>
<li><a href="http://www.allaboutadma.com/" class="external text" title="http://www.allaboutadma.com/" rel="nofollow">Summary of ADMA research literature</a></li>
<li><a href="http://www.adma.com" class="external text" title="http://www.adma.com" rel="nofollow">www.adma.com</a></li>
</ul>

<!-- 
Pre-expand include size: 97341 bytes
Post-expand include size: 37768 bytes
Template argument size: 26724 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/s/y/Asymmetric_dimethylarginine.html">http://en.wikipedia.org../../../a/s/y/Asymmetric_dimethylarginine.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../c/a/r/Category%7ECardiovascular_system_7ab6.html" title="Category:Cardiovascular system">Cardiovascular system</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/s/y/Asymmetric_dimethylarginine.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/s/y/Talk%7EAsymmetric_dimethylarginine_5dd1.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Asymmetric_dimethylarginine">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/d/m/ADMA_98c3.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E9%9D%9E/%E5%B0%8D/%E7%A8%B1/%E9%9D%9E%E5%B0%8D%E7%A8%B1%E6%80%A7%E4%BA%8C%E7%94%B2%E5%9F%BA%E7%B2%BE%E6%B0%A8%E9%85%B8.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 04:44, 21 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../a/l/i/User%7EAlison_304c.html" title="User:Alison">Alison</a>, <a href="../../../g/o/o/User%7EGoodbye_2_db0e.html" title="User:Goodbye 2">Goodbye 2</a>, <a href="../../../a/n/l/User%7EAnlace_5bdb.html" title="User:Anlace">Anlace</a>, <a href="../../../l/i/g/User%7ELigulem_20b6.html" title="User:Ligulem">Ligulem</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../r/m/k/User%7ERmky87_07f5.html" title="User:Rmky87">Rmky87</a>, <a href="../../../m/i/s/User%7EMisfitToys_23f7.html" title="User:MisfitToys">MisfitToys</a> and <a href="../../../m/i/d/User%7EMidgley_e5a1.html" title="User:Midgley">Midgley</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
